Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiarrhythmic drugs: how to evaluate them?

P Coumel1, A Leenhardt

  • 1Hôpital Lariboisière, Paris, France.

American Heart Journal
|April 1, 1994
PubMed
Summary

Current antiarrhythmic drug evaluation methods are insufficient for long-term outcomes in severe heart conditions. New assessment strategies are needed to understand drug efficacy in complex patient populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High prevalence of ventricular repolarization abnormalities in people carrying TGFβR2 mutations.

Scientific reports·2018
Same author

[Is atrial fibrillation an independent marker of cardiovascular risk?].

Annales de cardiologie et d'angeiologie·2011
Same author

[Pathophysiopathology of atrial fibrillation: applications to treatment].

Annales de cardiologie et d'angeiologie·2010
Same author

[Chloroquine cardiotoxicity in long-term lupus therapy in two patients].

Annales de dermatologie et de venereologie·2009
Same author

[Management of atrial fibrillation in France: the observational FACTUEL study].

Annales de cardiologie et d'angeiologie·2009
Same author

Cryoablation for curing reciprocating tachycardia: take the good and leave the bad.

Archives of cardiovascular diseases·2008

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Traditional antiarrhythmic drug evaluation relies on premature beat counts and electrophysiologic study inducibility.
  • These methods are effective for short-term assessment of Type I agents in stable arrhythmias but limited for complex cases.

Purpose of the Study:

  • To highlight the limitations of current antiarrhythmic drug assessment methods.
  • To advocate for new evaluation strategies focusing on responders and non-responders for long-term outcomes.

Main Methods:

  • Review of existing antiarrhythmic drug evaluation paradigms.
  • Discussion of the challenges in assessing new drug classes like beta-blockers and Type III agents.

Main Results:

  • Current quantitative methods inadequately predict long-term efficacy in severely diseased patients.
  • Existing approaches are not well-suited for newer antiarrhythmic drug classes.

Conclusions:

  • There is a critical need for improved, objective assessment methods for antiarrhythmic drugs.
  • Evaluating drug response in individual patients (responders vs. non-responders) is crucial for long-term management.

Related Experiment Videos